Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Non Operating Income (2016 - 2025)

Anaptysbio (ANAB) has disclosed Other Non Operating Income for 10 consecutive years, with -$3000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 114.29% year-over-year to -$3000.0, compared with a TTM value of $5.4 million through Dec 2025, up 38685.71%, and an annual FY2025 reading of $5.4 million, up 38685.71% over the prior year.
  • Other Non Operating Income was -$3000.0 for Q4 2025 at Anaptysbio, down from $3.5 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.5 million in Q2 2025 and bottomed at -$5000.0 in Q3 2024.
  • Average Other Non Operating Income over 5 years is $323000.0, with a median of $3000.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income crashed 600.0% in 2024, then skyrocketed 95200.0% in 2025.
  • Year by year, Other Non Operating Income stood at $1000.0 in 2021, then crashed by 500.0% to -$4000.0 in 2022, then soared by 50.0% to -$2000.0 in 2023, then surged by 1150.0% to $21000.0 in 2024, then plummeted by 114.29% to -$3000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for ANAB at -$3000.0 in Q4 2025, $3.5 million in Q2 2025, and $1.9 million in Q1 2025.